Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
15 Apr 2024 08:00 CEST |
CLARANOVA | Eric Gareau Appointed as CEO of Claranova | 10101015 Software | Journal / appointments |
15 Apr 2024 08:00 CEST |
EURONAV | Inkoop eigen aandelen | 50206030 Marine Transportation | Other subject |
15 Apr 2024 08:00 CEST |
Euronav Luxembourg SA 21/26 6.25pct USD C | Share buyback | - | Additional regulated information required to be disclosed under the laws of a Member State |
15 Apr 2024 07:58 CEST |
SOLOCAL GROUP | Resumption of trading | 40301030 Publishing | Legal |
15 Apr 2024 07:58 CEST |
SOLOCAL GROUP | Reprise des cotations | 40301030 Publishing | Legal |
15 Apr 2024 07:50 CEST |
ADP | Aéroports de Paris SA - Filing of the 2023 Universal Registration Document | 50206060 Transportation Services | Income |
15 Apr 2024 07:50 CEST |
ADP | Aéroports de Paris SA - Mise à disposition du document d\'enregistrement universel 2023 | 50206060 Transportation Services | Income |
15 Apr 2024 07:42 CEST |
NORDIC HALIBUT AS | Nordic Halibut AS – Thomas Scheele Berg appointed as new CFO | 45102010 Farming, Fishing, Ranching and Plantations | Non-regulatory press releases |
15 Apr 2024 07:35 CEST |
NORDIC HALIBUT AS | Nordic Halibut AS – Operational update Q1 2024 | 45102010 Farming, Fishing, Ranching and Plantations | Non-regulatory press releases |
15 Apr 2024 07:30 CEST |
ARGAN | ARGAN lance un nouveau projet labellisé Aut0nom® de 18 000 m² à Chartres | 35102030 Office REITs | New |
15 Apr 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
15 Apr 2024 07:30 CEST |
PHAXIAM THERAPEUTICS | PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureus | 20103010 Biotechnology | New |
15 Apr 2024 07:30 CEST |
PRYME N.V. | Taranis invests in Chemical Plastics Recycling Company, Pryme N.V. | 65103035 Waste and Disposal Services | Non-regulatory press releases |
15 Apr 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event | 20103010 Biotechnology | New |
15 Apr 2024 07:30 CEST |
ARGAN | ARGAN launches a new 18,000 sq.m Aut0nom® labelled project in Chartres | 35102030 Office REITs | New |
15 Apr 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
15 Apr 2024 07:30 CEST |
PHAXIAM THERAPEUTICS | PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus | 20103010 Biotechnology | New |
15 Apr 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma présente lors de l'EBMT 2024 des données positives pour MaaT013 à 18 mois montrant un avantage net en termes de survie globale dans l'aGvH dans son programme d'accès compassionnel | 20103010 Biotechnology | New |
15 Apr 2024 07:20 CEST |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
15 Apr 2024 07:19 CEST |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
15 Apr 2024 07:00 CEST |
BERGENBIO | BerGenBio ASA: Siste dag av den siste utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
15 Apr 2024 07:00 CEST |
BERGENBIO | BerGenBio ASA: Last day of the last exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
15 Apr 2024 07:00 CEST |
ELEKTROIMPORTØREN AS | Elektroimportøren AS: Annual Report 2023 | 40401030 Specialty Retailers | Annual financial and audit Reports |
15 Apr 2024 07:00 CEST |
Telenor ASA | Bytte av finansdirektør i Telenor | 15102015 Telecommunications Services | Innsideinformasjon |
15 Apr 2024 07:00 CEST |
INNATE PHARMA | Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients | 20103010 Biotechnology | Products and services |
15 Apr 2024 07:00 CEST |
BIOPHYTIS | Biophytis files a patent application and strengthens its intellectual property in obesity | 20103010 Biotechnology | Other subject |
15 Apr 2024 07:00 CEST |
INNATE PHARMA | L’Assemblée Générale d’Innate Pharma aura lieu le 23 mai 2024 | 20103010 Biotechnology | General meeting / Board Meeting |
15 Apr 2024 07:00 CEST |
PEXIP HOLDING | Ex. dividend NOK 1.1 today | 10101015 Software | Ex Date |
15 Apr 2024 07:00 CEST |
ULTIMOVACS | Ultimovacs ASA - Disclosure of voting rights of Annual General Meeting | 20103010 Biotechnology | Total number of voting rights and capital |
15 Apr 2024 07:00 CEST |
Telenor ASA | Change of CFO in Telenor Group | 15102015 Telecommunications Services | Inside information |
15 Apr 2024 07:00 CEST |
BIOPHYTIS | Biophytis dépose une demande de brevet et renforce sa propriété intellectuelle dans l’obésité | 20103010 Biotechnology | Other subject |
15 Apr 2024 07:00 CEST |
BenevolentAI | Proposed Changes to BenevolentAI’s Board Composition | 20103010 Biotechnology | Journal / appointments |
15 Apr 2024 07:00 CEST |
INNATE PHARMA | Innate Pharma annonce la progression de l’essai clinique évaluant le NK Cell Engager SAR443579 / IPH6101 développé par Sanofi vers la Phase 2 dans divers cancers du sang | 20103010 Biotechnology | Products and services |
15 Apr 2024 07:00 CEST |
INNATE PHARMA | Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024 | 20103010 Biotechnology | General meeting / Board Meeting |
14 Apr 2024 19:34 CEST |
OTELLO CORPORATION | Otello Corporation share buyback program status | 10101020 Consumer Digital Services | Acquisition or disposal of the issuer’s own shares |
14 Apr 2024 12:45 CEST |
AGEAS | Ageas prend acte du fait que BNP Paribas devient actionnaire | 30301010 Life Insurance | - |
14 Apr 2024 12:45 CEST |
AGEAS | Ageas neemt akte van BNP Paribas’ aandeelhoudershap | 30301010 Life Insurance | - |
14 Apr 2024 12:45 CEST |
AGEAS | Ageas acknowledges BNP Paribas as shareholder | 30301010 Life Insurance | - |
14 Apr 2024 12:00 CEST |
BNP PARIBAS | BNP Paribas signe un accord avec le Groupe Fosun pour le rachat de sa participation dans ageas | 30101010 Banks | Mergers, Acquiqitions, Transferts |
14 Apr 2024 12:00 CEST |
BNP PARIBAS | BNP Paribas has signed an agreement with Fosun Group to acquire its stake in ageas | 30101010 Banks | Mergers, Acquiqitions, Transferts |
13 Apr 2024 18:39 CEST |
GOLDEN ENERGY OFFSHORE SERVICES | Financial calendar | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
13 Apr 2024 18:39 CEST |
GOLDEN ENERGY OFFSHORE SERVICES | Finansiell kalender | 60101030 Oil Equipment and Services | Annen informasjonspliktig regulatorisk informasjon |
13 Apr 2024 12:01 CEST |
XXL | XXL ASA – Disclosure of shareholding | 40401020 Apparel Retailers | Major shareholding notifications |
13 Apr 2024 12:00 CEST |
XXL | XXL ASA – Mandatory notification of trade | 40401020 Apparel Retailers | Mandatory notification of trade primary insiders |
13 Apr 2024 10:13 CEST |
RAMADA INVESTIMENTOS E INDUSTRIA S.A. | Ramada Investimentos e Indústria, S.A. informs notice convening the Shareholders Annual General Meeting on May 3, 2024 - RECTIFIED | 55102010 Iron and Steel | Other subject |
13 Apr 2024 10:07 CEST |
RAMADA INVESTIMENTOS E INDUSTRIA S.A. | Ramada Investimentos e Indústria, S.A. informa sobre Convocatória para a Assembleia Geral de Acionistas de 3 de maio de 2024- RETIFICAÇÃO | 55102010 Iron and Steel | Other subject |
12 Apr 2024 23:14 CEST |
ALTRI SGPS | Altri, SGPS, S.A. announces notice convening the Shareholders Annual General Meeting on May 3, 2024 - RECTIFIED | 55101015 Paper | General meeting / Board Meeting |
12 Apr 2024 23:14 CEST |
ALTRI SGPS | Altri, SGPS, S.A. informa sobre Convocatória para a Assembleia Geral de Acionistas de 3 de maio de 2024 - RETIFICAÇÃO | 55101015 Paper | General meeting / Board Meeting |
12 Apr 2024 20:05 CEST |
SANOFI | Sanofi: Information concerning the total number of voting rights and shares - March 2024 | 20103015 Pharmaceuticals | Share history |
12 Apr 2024 20:05 CEST |
SANOFI | Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024 | 20103015 Pharmaceuticals | Share history |